|
[Related PubMed/MEDLINE]
Total Number of Papers: 1614
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: DA |
| Long Form |
: dopaminergic |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Dopaminergic modulation of olfactory-evoked motor output in sea lampreys (Petromyzon marinus L.). |
OB |
| 2 |
2020 |
Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra. |
AAVs, GFAP, GLT-1, PD, PSD-95, shRNA, siRNAs, SNpc |
| 3 |
2020 |
Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model. |
DAT, GFAP, Iba1, MPTP, NEIL1, PD, TH |
| 4 |
2020 |
Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence. |
nAChRs |
| 5 |
2020 |
Preclinical evaluation of patient-derived cells shows promise for Parkinson's disease. |
iPSCs, PD |
| 6 |
2020 |
Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. |
HFD, LPS, ROT |
| 7 |
2020 |
Thioredoxin-Interacting Protein (TXNIP) Regulates Parkin/PINK1-mediated Mitophagy in Dopaminergic Neurons Under High-glucose Conditions: Implications for Molecular Links Between Parkinson's Disease and Diabetes. |
CCCP, HG, PD, ROS, TXNIP |
| 8 |
2019 |
A Neuron-Glial Trans-Signaling Cascade Mediates LRRK2-Induced Neurodegeneration. |
BMP, Gbb, LRRK2, pMad |
| 9 |
2019 |
A test of dopamine hyper- and hyposensitivity in alcohol use. |
FRN |
| 10 |
2019 |
AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease. |
alpha-syn-WT, GFP, PD, SNpc |
| 11 |
2019 |
Activation of Peroxisome Proliferator-Activated Receptor-alpha Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons. |
Nurr1, PD, PPAR |
| 12 |
2019 |
Acute Tramadol-Induced Cellular Tolerance and Dependence of Ventral Tegmental Area Dopaminergic Neurons: An In Vivo Electrophysiological Study. |
VTA |
| 13 |
2019 |
Age-Associated Dopaminergic Neuron Loss and Midbrain Glia Cell Phenotypic Polarization. |
Arg1, BDNF, GDNF, IL-1beta, Lcn2, TNF-alpha |
| 14 |
2019 |
Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. |
alpha-Syn, ClpP, PD, SOD2 |
| 15 |
2019 |
Alterations and adaptation of ventral tegmental area dopaminergic neurons in animal models of depression. |
VTA |
| 16 |
2019 |
Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism. |
DA1, DMV, PD |
| 17 |
2019 |
Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging. |
FC, VTA |
| 18 |
2019 |
AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression. |
AMPK, pAMPK, PD, SNpc |
| 19 |
2019 |
Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota. |
AQ, BU, BW, CT, EA, ET, PD |
| 20 |
2019 |
Anticancer Drugs for Parkinson's Disease: Is It a Ray of Hope or Only Hype? |
PD |
| 21 |
2019 |
Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity. |
DPSCs, GFAP, NO |
| 22 |
2019 |
Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus. |
AREs, hPSCs, PD, PKC, SN |
| 23 |
2019 |
Biochanin A protects against angiotensin II-induced damage of dopaminergic neurons in rats associated with the increased endophilin A2 expression. |
Ang II, AT1R, EPA2, GPCR |
| 24 |
2019 |
Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson's Disease. |
GAP43, MPTP, PD, TH, VEGF |
| 25 |
2019 |
Central Processing of Itch in the Midbrain Reward Center. |
GABA, VTA |
| 26 |
2019 |
Cigarette smoke during lactation in rat female progeny: Late effects on endocannabinoid and dopaminergic systems. |
ARC, CS, DAGL, DAT, EC, LH, PFC |
| 27 |
2019 |
Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF. |
CRE, CREB, GDNF, PD, PKA, SNpc |
| 28 |
2019 |
Cocaine Directly Inhibits alpha6-Containing Nicotinic Acetylcholine Receptors in Human SH-EP1 Cells and Mouse VTA DA Neurons. |
sIPSCs, VTA |
| 29 |
2019 |
Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson's Disease. |
NHPs, PD, SNpc |
| 30 |
2019 |
Comparison between dopaminergic and non-dopaminergic neurons in the VTA following chronic nicotine exposure during pregnancy. |
ECM, non-DA, VTA |
| 31 |
2019 |
Conditional Haploinsufficiency of beta-Catenin Aggravates Neuronal Damage in a Paraquat-Based Mouse Model of Parkinson Disease. |
PD, PQ |
| 32 |
2019 |
Cordycepin mitigates MPTP-induced Parkinson's disease through inhibiting TLR/NF-kappaB signaling pathway. |
LPS, PD, TH |
| 33 |
2019 |
Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease. |
MPTP, MQC, PD, SNpc |
| 34 |
2019 |
Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway. |
GP, PD, VMAT2 |
| 35 |
2019 |
Differential effect of modafinil on impulsivity, attention and motor activity in preadolescent rats prenatally treated with alcohol. |
PA, PS |
| 36 |
2019 |
Differentiation of Neural Stem Cells Derived from Induced Pluripotent Stem Cells into Dopaminergic Neurons. |
CNS, DIFs, iPSCs, NSCs, PD |
| 37 |
2019 |
DKK1 expression is suppressed by miR-9 during induced dopaminergic differentiation of human trabecular meshwork mesenchymal stem cells. |
TM-MSCs |
| 38 |
2019 |
Dose-dependent effects of estrogen on prediction error related neural activity in the nucleus accumbens of healthy young women. |
NAc, PE |
| 39 |
2019 |
Dysfunction of Cellular Proteostasis in Parkinson's Disease. |
alpha-Syn, ER, PD, UPR |
| 40 |
2019 |
Echoes of Emotions Past: How Neuromodulators Determine What We Recollect. |
LC-NE, NE |
| 41 |
2019 |
Effects of brief inhibition of the ventral tegmental area dopamine neurons on the cocaine seeking during abstinence. |
CS, TH, VTA |
| 42 |
2019 |
Effects of Silibinin Against Prothrombin Kringle-2-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System In Vivo. |
PD, pKr-2 |
| 43 |
2019 |
Electrical Abnormalities in Dopaminergic Neurons of the Substantia Nigra in Mice With an Aromatic L-Amino Acid Decarboxylase Deficiency. |
AADC, AHP, APs, sEPSCs, sIPSCs, SNc |
| 44 |
2019 |
Elevated dopamine signaling from ventral tegmental area to prefrontal cortical parvalbumin neurons drives conditioned inhibition. |
dmPFC, PV, SL, VTA |
| 45 |
2019 |
Emergence of novel functions in striatal low-threshold spike interneurons. |
GLU, SPNs, top |
| 46 |
2019 |
Extensive exploration of a novel rat model of Parkinson's disease using partial 6-hydroxydopamine lesion of dopaminergic neurons suggests newtherapeutic approaches. |
DAT, PD, PET, TH, TSPO |
| 47 |
2019 |
EZH2 Is Essential for Fate Determination in the Mammalian Isthmic Area. |
cKOs, IsO, NPCs, PcGs, PRC2 |
| 48 |
2019 |
FGF-2 isoforms influence the development of dopaminergic neurons in the murine substantia nigra, but not anxiety-like behavior, stress susceptibility, or locomotor behavior. |
CNS, FGF-2, HMW, SNpc |
| 49 |
2019 |
FoxO1 regulates leptin-induced mood behavior by targeting tyrosine hydroxylase. |
FOXO1, STAT3, TH |
| 50 |
2019 |
Functional dopaminergic neurons derived from human chorionic mesenchymal stem cells ameliorate striatal atrophy and improve behavioral deficits in Parkinsonian rat model. |
HCMSCs, PD |
| 51 |
2019 |
GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease. |
aSyn, dm, GBA, PD |
| 52 |
2019 |
Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson's Disease. |
CNS, PD |
| 53 |
2019 |
Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes. |
hSSCs, OEC-CM, PD |
| 54 |
2019 |
Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies. |
iNSCs, PBMNCs, PD, SeV, SNpc, VM |
| 55 |
2019 |
Gold nanoclusters for Parkinson's disease treatment. |
L-NIBC, PD, WB |
| 56 |
2019 |
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases. |
hESC, NO, PD |
| 57 |
2019 |
Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease. |
BDNF, bFGF, FGF8, GDNF, OE-MSCs, PD, SHH |
| 58 |
2019 |
Impact of Sleep-Wake-Associated Neuromodulators and Repetitive Low-Frequency Stimulation on Human iPSC-Derived Neurons. |
iPSC, LFS, LTD, SBFs |
| 59 |
2019 |
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease. |
AIH, EPM, NOR, PD, SI, SNc |
| 60 |
2019 |
Induction of Tyrosine Hydroxylase Gene Expression in Embryonal Carcinoma Stem Cells Using a Natural Tissue-Specific Inducer. |
NRBE |
| 61 |
2019 |
Inhibition of Ezh2 In Vitro and the Decline of Ezh2 in Developing Midbrain Promote Dopaminergic Neurons Differentiation Through Modifying H3K27me3. |
VM-NSCs |
| 62 |
2019 |
Innate immune responses to paraquat exposure in a Drosophila model of Parkinson's disease. |
PD, PQ |
| 63 |
2019 |
Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing. |
MSA, PD, SN |
| 64 |
2019 |
Ketamine increases the expression of GluR1 and GluR2 alpha-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells. |
--- |
| 65 |
2019 |
Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy. |
KO, PD, SNc |
| 66 |
2019 |
Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson's disease. |
dR, mito-dR, PD |
| 67 |
2019 |
Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson's disease. |
dR, mito-dR, PD |
| 68 |
2019 |
LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson's disease through RAB3IP. |
ceRNAs, PD, qRT-PCR, RIP |
| 69 |
2019 |
Long non-coding RNA repertoire and open chromatin regions constitute midbrain dopaminergic neuron - specific molecular signatures. |
lncRNAs |
| 70 |
2019 |
Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease. |
CREB, FMRP, FXS, ILBD, MMP9, PD, PKC, SNc |
| 71 |
2019 |
Loss of Midbrain Dopamine Neurons and Altered Apomorphine EEG Effects in the 5xFAD Mouse Model of Alzheimer's Disease. |
AD, APO, EEGs, MC, SN, VTA |
| 72 |
2019 |
Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. |
EOPD, PD |
| 73 |
2019 |
LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients. |
GCase, PD |
| 74 |
2019 |
MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling. |
Eya, GDNF, Six2 |
| 75 |
2019 |
Modeling Parkinson's disease in adult Drosophila. |
PD |
| 76 |
2019 |
Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death. |
AD, MS |
| 77 |
2019 |
NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation. |
NADPH, PD, ROS, SNpc |
| 78 |
2019 |
Naringenin targets on astroglial Nrf2 to support dopaminergic neurons. |
NAR, Nrf2, PD |
| 79 |
2019 |
NCS-1 Deficiency Affects mRNA Levels of Genes Involved in Regulation of ATP Synthesis and Mitochondrial Stress in Highly Vulnerable Substantia nigra Dopaminergic Neurons. |
PD, SN, UCPs |
| 80 |
2019 |
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe. |
LSD, MDMA, mPFC, NAc, PPI |
| 81 |
2019 |
Neurochemical and neuroinflammatory perturbations in two Gulf War Illness models: Modulation by the immunotherapeutic LNFPIII. |
CORT, DEET, DFP, GW, GWI, LNFPIII, PB, PM |
| 82 |
2019 |
Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease. |
ELISA, GDNF, GFAP, IBA1, MPTP, PD, SN, SNpc, TH, VTA |
| 83 |
2019 |
NF-kappaB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols. |
NF-kappaB, PD |
| 84 |
2019 |
NIPSNAP1 and NIPSNAP2 Act as "Eat Me" Signals for Mitophagy. |
NIPSNAP1 |
| 85 |
2019 |
Olfactory ensheathing cells improve the survival of porcine neural xenografts in a Parkinsonian rat model. |
hfVM, OECs, PD, pfVM |
| 86 |
2019 |
One Step Into the Future: New iPSC Tools to Advance Research in Parkinson's Disease and Neurological Disorders. |
iPSC, PD |
| 87 |
2019 |
Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: Impact on alpha-synuclein protein levels. |
AhR, PD, PRKN |
| 88 |
2019 |
Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells. |
HDs, iPSCs, NTFs, PD, SN, TDNs |
| 89 |
2019 |
Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and alpha-synuclein stability through membrane remodeling. |
alpha-Syn, ER, PD |
| 90 |
2019 |
Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons. |
PD, SAPNS |
| 91 |
2019 |
Peripheral nerve injury-induced alterations in VTA neuron firing properties. |
VTA |
| 92 |
2019 |
Peroxiredoxin 5 Silencing Sensitizes Dopaminergic Neuronal Cells to Rotenone via DNA Damage-Triggered ATM/p53/PUMA Signaling-Mediated Apoptosis. |
ATM, PD, Prxs |
| 93 |
2019 |
Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson's disease. |
PD, SNpc |
| 94 |
2019 |
Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus. |
DBS, PD, SNpc, STN |
| 95 |
2019 |
Prenatal Ethanol Exposure and Postnatal Environmental Intervention Alter Dopaminergic Neuron and Microglia Morphology in the Ventral Tegmental Area During Adulthood. |
FASD, PE, VTA |
| 96 |
2019 |
Procyanidin protects against 6-hydroxydopamine-induced dopaminergic neuron damage via the regulation of the PI3K/Akt signalling pathway. |
MMP, PC, PD, PI3K, SOD |
| 97 |
2019 |
Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro. |
--- |
| 98 |
2019 |
Robustness to Axon Initial Segment Variation Is Explained by Somatodendritic Excitability in Rat Substantia Nigra Dopaminergic Neurons. |
ABD, AIS, AP |
| 99 |
2019 |
Role of gold nanoparticle from Cinnamomum verum against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mice model. |
IL-1beta, IL-6, MPTP, PD, TNF-alpha |
| 100 |
2019 |
Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy. |
PD, Sal |
|
A Search Service for Abbreviation / Long Form
